Posttransplant diabetes mellitus in a pediatric kidney transplant recipient with a family history of Type 2DM

Abstract

 We report on a 12-year-old girl with posttransplant diabetes mellitus (PTDM) who had a family history of type 2DM.
 She received TAC-based immunosuppression as the pretransplant OGTT showed normal glucose tolerance. She was managed with insulin therapy for 2 months after the onset PTDM and able to discontinue insulin therapy after conversion to CyA. We believe that conversion to CyA is effective to early presentation of PTDM and one should consider avoiding the use of tacrolimus in patients with a family history of Type 2DM.